Skip to content

Net margin at other companies

Abbott logo
AbbottABT
13.9%-18.0pp
Boston Scientific logo
Boston ScientificBSX
17.3%+5.7pp
IAR
Integra LifeSciencesIART
-30.1%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
9.1%-2.8pp
Medtronic logo
MedtronicMDT
13.2%-0.7pp
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-21.7%-4.5pp

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Calculated from ClearPoint Neuro’s reported figures.

Based on trailing twelve months.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's net margin?
ClearPoint Neuro (CLPT) reported net margin of -71.6% in Q1 2026.
How has ClearPoint Neuro's net margin changed year-over-year?
ClearPoint Neuro's net margin decreased by 10.9% year-over-year, from -64.5% to -71.6%.
What is the long-term trend for ClearPoint Neuro's net margin?
Over 5 years (2020 to 2025), ClearPoint Neuro's net margin has grown at a 5.5% compound annual growth rate (CAGR), from -52.9% to -69.1%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.